Vascular Biogenics Ltd. , a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States.
Vascular Biogenics stock last closed at $0.17, down 1.18% from the previous day, and has decreased 90.4% in one year. It has underperformed other stocks in the Biotechnology industry by 0.64 percentage points. Vascular Biogenics stock is currently +66.34% from its 52-week low of $0.10, and -92.36% from its 52-week high of $2.20.
At the moment, there are 69.75M VBLT shares outstanding. The market value of VBLT is $11.72M. In the past 24 hours, 609,633 VBLT shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy VBLT shares.
Based on our analysis, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today.Open eToro Account
Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to invest in VBLT stock today.
Now that you've opened your account on the stock trading app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your investment account.
After you have figured out the best place to buy Vascular Biogenics stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was designed to help average investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on VBLT's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge VBLT's fair value.
Using relative valuations methods:
You can do more valuation research on VBLT's stock here.
Last year, VBLT earnings were -$32.30M. In the last 5 year, VBLT's earnings have increased by 2.57% per year. This was slower than the Biotechnology industry average of 64.46%.
Last year, VBLT revenue was $658.00k. In the past five year, VBLT's revenue has increased by -45.64% per year. This was slower than the Biotechnology industry average of 41.18%.
Find out more about VBLT's earnings and revenue performance here.
In the last year, insiders at VBLT have not bought or sold any shares.
Learn more about who owns VBLT shares here.
No, Vascular Biogenics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary order types:
Press the Open button and your broker will place the order.
If you need more help with buying stocks on eToro, watch the how to video below:
Now that you own some shares in VBLT, you'll want to keep up with your stock purchase.
Create a watchlist to get the latest updates about your VBLT stock.
To summarize, here are the 6 steps you need to take to buy Vascular Biogenics stock right now:
If you need a place to buy stocks, eToro is our favorite venue.Get Started with eToro Today
If you would like to keep an eye on your investment in Vascular Biogenics, click below.
How much does it cost to buy one Vascular Biogenics share?
What is the best way to buy Vascular Biogenics stock?